A small U.S. study of rectal cancer patients with a certain mutation found that every single person treated with an immunotherapy drug had their cancer "disappear" without the need for further ...
In a recent study published in Nature Genetics, researchers evaluated sensitivity to immune checkpoint blockade (ICB) therapy in autochthonous mouse models of DNA mismatch repair (MMR) deficiency ...
Grade III-IV cytokine release syndrome is associated with inferior survival in patients undergoing haploidentical donor stem cell transplants. This is an ASCO Meeting Abstract from the 2020 ASCO ...
The results of a small clinical trial have found that there could be a cure for rectal cancer. The trial — conducted by Memorial Sloan Kettering Cancer Center in Manhattan — involved at least 12 ...
Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...
Please provide your email address to receive an email when new articles are posted on . Avelumab induced promising activity among women with mismatch repair-deficient endometrial cancer regardless of ...
Patients with mismatch repair deficient gastric cancer demonstrated better median overall survival when skipping perioperative chemotherapy, according to a preprint study. Median overall survival is ...
Testing the impact of adjuvant radiotherapy (aRT) after radical prostatectomy (RP) on overall mortality (OM) in prostate cancer patients with pathologically node positive disease: A nationwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results